Huhtamäki has generally done its job as well as can be expected in the prevailing market situation. The dividend is developing well and indebtedness is on a downward trend.
I would give a clean bill of health to the analysts who have been on the “add” side for a long time, because the decline in valuation levels cannot be priced to continue forever.
Often it sounds like people are more worried about the share price development than the business. This is naturally completely pointless if other things are handled properly and in an upward direction. The company will continue to have good, bad, and steady times regarding share price development.
Consider the years 2010-2016, for example; the company’s value multiplied (10e—40e).
Huhtamäki’s dividend in 2016 was 0.73e per share, and in a few years, it will be double that. So, with one share, you now get significantly more value than, say, 10 years ago.
I’ve also noticed that share prices and company CEOs don’t call your phone to tell you when they are on sale. You have to be patient and trust that things will normalize in the long run.